| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.209 | 35.225 | 35.943 | 33.822 | 34.983 | 56.878 | 91.009 | 124.986 | 125.426 |
| Total Income - EUR | - | 7.209 | 35.248 | 35.944 | 34.501 | 34.983 | 56.881 | 91.010 | 124.986 | 131.060 |
| Total Expenses - EUR | - | 319 | 1.693 | 1.864 | 3.176 | 2.689 | 4.423 | 10.881 | 20.873 | 22.497 |
| Gross Profit/Loss - EUR | - | 6.891 | 33.555 | 34.080 | 31.325 | 32.294 | 52.458 | 80.129 | 104.113 | 108.563 |
| Net Profit/Loss - EUR | - | 6.674 | 32.497 | 33.001 | 30.357 | 31.359 | 51.203 | 78.507 | 103.104 | 104.711 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Vimarton Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 490 | 206 | 1.274 | 2.023 | 1.713 |
| Current Assets | - | 7.327 | 33.833 | 34.558 | 30.664 | 31.231 | 51.615 | 78.459 | 128.688 | 106.224 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.605 | 328 | 4.016 | 0 | 15.233 | 8.915 | 52.824 | 7.349 | 78.738 |
| Cash | - | 5.722 | 33.505 | 30.542 | 30.664 | 15.998 | 42.700 | 25.636 | 121.339 | 27.486 |
| Shareholders Funds | - | 6.719 | 32.541 | 33.044 | 30.407 | 31.408 | 51.252 | 78.556 | 128.759 | 104.759 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 608 | 1.292 | 1.513 | 257 | 313 | 569 | 1.178 | 1.952 | 3.177 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vimarton Med Srl